[LXRX] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 12.37%
YoY- 14.70%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 13,753 25,207 33,047 26,942 12,053 18,293 23,037 -29.16%
PBT -34,706 -42,075 -32,387 -30,722 -35,059 -43,543 -32,419 4.66%
Tax 6,097 6,119 -4,009 2,034 2,062 -8,652 37 2933.91%
NP -34,706 -42,075 -28,378 -30,722 -35,059 -34,891 -32,419 4.66%
Tax Rate - - - - - - - -
Total Cost 48,459 67,282 61,425 57,664 47,112 53,184 55,456 -8.62%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -252.35 -166.92 -85.87 -114.03 -290.87 -190.73 -140.73 47.75%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.33 -0.40 -0.27 -0.29 -0.33 -0.33 -0.31 4.26%
EPS Diluted -0.33 -0.40 -0.27 -0.29 -0.33 -0.33 -0.31 4.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.